BARBARA CASUSO: Open Payments
NPI 1912445644 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,567 in 80 payments from 14 companies in 2025. Trend: 2023 $1,465 · 2024 $3,334 · 2025 $2,567
Food & beverage: $2,458Education: $110
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $687 |
| ABBVIE INC. | 11 | $468 |
| Incyte Corporation | 8 | $230 |
| UCB, Inc. | 5 | $190 |
| PFIZER INC. | 11 | $187 |
| GENZYME CORPORATION | 8 | $181 |
| LEO Pharma Inc. | 5 | $173 |
| Journey Medical Corporation | 1 | $97 |
| Galderma Laboratories, L.P. | 5 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
Products named: TREMFYA, RINVOQ, OPZELURA, SKYRIZI, Bimzelx, DUPIXENT, ANZUPGO, CIBINQO.
Industry payments across NY — which companies pay providers there.
